我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
15
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
9
60.0%
终止
1
6.7%
Unknown
3
20.0%
撤回
2
13.3%
暂无批准数据
- Cancer diagnosis rates in people under age 50 rose roughly 22% from 2000 to 2023, driving rapid growth in the oncofertility field. - Fertility preservation consultations for cancer patients surged, with Boston IVF's New England clinics rising from 19 patients in 2015 to 183 in 2025. - A Dana-Farber trial found early, hormone-sensitive breast cancer survivors could pause hormone therapy for up to two years to conceive without raising recurrence risk. - Despite progress, patients still face barriers including time pressure, limited awareness, and high out-of-pocket costs for fertility preservation.
